State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Breast (Late Stage^), 2017-2021

All Races (includes Hispanic), Female, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 42.0 with a 95% confidence interval from 41.9 to 42.2 and 80,548 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 31.2

Wyoming⁶

• Rate : The incidence rate is 42.2 with a 95% confidence interval from 38.9 to 45.7 and 138 average annual cases over 2017-2021.
• CI*Rank ⋔ : 23 (2, 48)
• Percent of Cases with Late Stage : 32.7

Alaska⁶

• Rate : The incidence rate is 40.4 with a 95% confidence interval from 37.4 to 43.6 and 146 average annual cases over 2017-2021.
• CI*Rank ⋔ : 38 (6, 49)
• Percent of Cases with Late Stage : 31.5

Vermont⁶

• Rate : The incidence rate is 37.3 with a 95% confidence interval from 34.5 to 40.3 and 153 average annual cases over 2017-2021.
• CI*Rank ⋔ : 48 (27, 50)
• Percent of Cases with Late Stage : 27.1

North Dakota⁶

• Rate : The incidence rate is 41.3 with a 95% confidence interval from 38.4 to 44.3 and 168 average annual cases over 2017-2021.
• CI*Rank ⋔ : 32 (4, 49)
• Percent of Cases with Late Stage : 30.2

District of Columbia⁶

• Rate : The incidence rate is 48.1 with a 95% confidence interval from 44.8 to 51.5 and 170 average annual cases over 2017-2021.
• CI*Rank ⋔ : 1 (1, 19)
• Percent of Cases with Late Stage : 33.9

South Dakota⁶

• Rate : The incidence rate is 39.6 with a 95% confidence interval from 37.0 to 42.3 and 198 average annual cases over 2017-2021.
• CI*Rank ⋔ : 44 (14, 49)
• Percent of Cases with Late Stage : 29.5

Rhode Island⁶

• Rate : The incidence rate is 38.4 with a 95% confidence interval from 36.2 to 40.7 and 260 average annual cases over 2017-2021.
• CI*Rank ⋔ : 47 (27, 50)
• Percent of Cases with Late Stage : 26.0

Montana⁶

• Rate : The incidence rate is 42.7 with a 95% confidence interval from 40.3 to 45.2 and 276 average annual cases over 2017-2021.
• CI*Rank ⋔ : 20 (3, 45)
• Percent of Cases with Late Stage : 29.5

Delaware⁶

• Rate : The incidence rate is 43.9 with a 95% confidence interval from 41.5 to 46.5 and 276 average annual cases over 2017-2021.
• CI*Rank ⋔ : 11 (1, 41)
• Percent of Cases with Late Stage : 29.5

New Hampshire⁶

• Rate : The incidence rate is 40.5 with a 95% confidence interval from 38.5 to 42.5 and 357 average annual cases over 2017-2021.
• CI*Rank ⋔ : 37 (14, 48)
• Percent of Cases with Late Stage : 27.6

Hawaii³

• Rate : The incidence rate is 41.5 with a 95% confidence interval from 39.5 to 43.6 and 363 average annual cases over 2017-2021.
• CI*Rank ⋔ : 30 (7, 47)
• Percent of Cases with Late Stage : 28.3

Maine⁶

• Rate : The incidence rate is 40.1 with a 95% confidence interval from 38.1 to 42.1 and 372 average annual cases over 2017-2021.
• CI*Rank ⋔ : 41 (16, 48)
• Percent of Cases with Late Stage : 28.3

Idaho³

• Rate : The incidence rate is 44.9 with a 95% confidence interval from 43.0 to 46.9 and 445 average annual cases over 2017-2021.
• CI*Rank ⋔ : 6 (1, 25)
• Percent of Cases with Late Stage : 32.0

Nebraska⁶

• Rate : The incidence rate is 42.7 with a 95% confidence interval from 40.9 to 44.6 and 464 average annual cases over 2017-2021.
• CI*Rank ⋔ : 19 (4, 42)
• Percent of Cases with Late Stage : 31.4

New Mexico³

• Rate : The incidence rate is 39.4 with a 95% confidence interval from 37.7 to 41.0 and 498 average annual cases over 2017-2021.
• CI*Rank ⋔ : 45 (26, 49)
• Percent of Cases with Late Stage : 32.1

West Virginia⁶

• Rate : The incidence rate is 42.9 with a 95% confidence interval from 41.2 to 44.8 and 507 average annual cases over 2017-2021.
• CI*Rank ⋔ : 17 (4, 40)
• Percent of Cases with Late Stage : 32.4

Utah³

• Rate : The incidence rate is 41.6 with a 95% confidence interval from 40.2 to 43.2 and 605 average annual cases over 2017-2021.
• CI*Rank ⋔ : 29 (11, 44)
• Percent of Cases with Late Stage : 34.5

Nevada⁶

• Rate : The incidence rate is 39.1 with a 95% confidence interval from 37.8 to 40.5 and 689 average annual cases over 2017-2021.
• CI*Rank ⋔ : 46 (31, 49)
• Percent of Cases with Late Stage : 33.5

Kansas⁶

• Rate : The incidence rate is 41.8 with a 95% confidence interval from 40.4 to 43.3 and 703 average annual cases over 2017-2021.
• CI*Rank ⋔ : 27 (10, 43)
• Percent of Cases with Late Stage : 29.8

Puerto Rico⁶

• Rate : The incidence rate is 34.4 with a 95% confidence interval from 33.2 to 35.6 and 714 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 33.2

Arkansas⁶

• Rate : The incidence rate is 39.8 with a 95% confidence interval from 38.5 to 41.2 and 721 average annual cases over 2017-2021.
• CI*Rank ⋔ : 42 (25, 48)
• Percent of Cases with Late Stage : 30.8

Iowa³

• Rate : The incidence rate is 42.7 with a 95% confidence interval from 41.3 to 44.1 and 806 average annual cases over 2017-2021.
• CI*Rank ⋔ : 18 (6, 37)
• Percent of Cases with Late Stage : 29.9

Mississippi⁶

• Rate : The incidence rate is 45.8 with a 95% confidence interval from 44.4 to 47.3 and 827 average annual cases over 2017-2021.
• CI*Rank ⋔ : 4 (1, 13)
• Percent of Cases with Late Stage : 35.8

Connecticut³

• Rate : The incidence rate is 41.4 with a 95% confidence interval from 40.1 to 42.6 and 939 average annual cases over 2017-2021.
• CI*Rank ⋔ : 31 (14, 44)
• Percent of Cases with Late Stage : 27.7

Oklahoma⁶

• Rate : The incidence rate is 43.2 with a 95% confidence interval from 42.0 to 44.5 and 982 average annual cases over 2017-2021.
• CI*Rank ⋔ : 14 (6, 32)
• Percent of Cases with Late Stage : 33.4

Oregon⁶

• Rate : The incidence rate is 40.2 with a 95% confidence interval from 39.1 to 41.4 and 1,032 average annual cases over 2017-2021.
• CI*Rank ⋔ : 40 (25, 47)
• Percent of Cases with Late Stage : 29.1

Kentucky³

• Rate : The incidence rate is 42.0 with a 95% confidence interval from 40.8 to 43.1 and 1,152 average annual cases over 2017-2021.
• CI*Rank ⋔ : 24 (12, 40)
• Percent of Cases with Late Stage : 31.4

Alabama⁶

• Rate : The incidence rate is 39.8 with a 95% confidence interval from 38.8 to 40.8 and 1,239 average annual cases over 2017-2021.
• CI*Rank ⋔ : 43 (30, 48)
• Percent of Cases with Late Stage : 31.1

Louisiana³

• Rate : The incidence rate is 46.8 with a 95% confidence interval from 45.6 to 48.0 and 1,291 average annual cases over 2017-2021.
• CI*Rank ⋔ : 3 (1, 7)
• Percent of Cases with Late Stage : 34.8

Colorado⁶

• Rate : The incidence rate is 43.0 with a 95% confidence interval from 41.9 to 44.0 and 1,359 average annual cases over 2017-2021.
• CI*Rank ⋔ : 16 (7, 32)
• Percent of Cases with Late Stage : 31.3

Minnesota⁶

• Rate : The incidence rate is 41.9 with a 95% confidence interval from 40.9 to 43.0 and 1,363 average annual cases over 2017-2021.
• CI*Rank ⋔ : 25 (13, 39)
• Percent of Cases with Late Stage : 28.5

South Carolina⁶

• Rate : The incidence rate is 44.2 with a 95% confidence interval from 43.2 to 45.3 and 1,406 average annual cases over 2017-2021.
• CI*Rank ⋔ : 9 (4, 21)
• Percent of Cases with Late Stage : 31.4

Wisconsin⁶

• Rate : The incidence rate is 42.5 with a 95% confidence interval from 41.5 to 43.5 and 1,491 average annual cases over 2017-2021.
• CI*Rank ⋔ : 22 (10, 35)
• Percent of Cases with Late Stage : 29.5

Arizona⁶

• Rate : The incidence rate is 37.0 with a 95% confidence interval from 36.1 to 37.9 and 1,548 average annual cases over 2017-2021.
• CI*Rank ⋔ : 49 (46, 50)
• Percent of Cases with Late Stage : 29.7

Missouri⁶

• Rate : The incidence rate is 43.7 with a 95% confidence interval from 42.7 to 44.7 and 1,630 average annual cases over 2017-2021.
• CI*Rank ⋔ : 13 (5, 24)
• Percent of Cases with Late Stage : 31.5

Maryland⁶

• Rate : The incidence rate is 44.4 with a 95% confidence interval from 43.4 to 45.4 and 1,668 average annual cases over 2017-2021.
• CI*Rank ⋔ : 8 (4, 19)
• Percent of Cases with Late Stage : 31.7

Tennessee⁶

• Rate : The incidence rate is 41.1 with a 95% confidence interval from 40.2 to 42.0 and 1,721 average annual cases over 2017-2021.
• CI*Rank ⋔ : 34 (20, 43)
• Percent of Cases with Late Stage : 31.6

Washington⁵

• Rate : The incidence rate is 43.8 with a 95% confidence interval from 42.9 to 44.7 and 1,899 average annual cases over 2017-2021.
• CI*Rank ⋔ : 12 (5, 23)
• Percent of Cases with Late Stage : 30.6

Virginia⁶

• Rate : The incidence rate is 41.3 with a 95% confidence interval from 40.4 to 42.1 and 2,110 average annual cases over 2017-2021.
• CI*Rank ⋔ : 33 (20, 42)
• Percent of Cases with Late Stage : 30.9

New Jersey³

• Rate : The incidence rate is 43.1 with a 95% confidence interval from 42.3 to 43.9 and 2,455 average annual cases over 2017-2021.
• CI*Rank ⋔ : 15 (8, 27)
• Percent of Cases with Late Stage : 30.6

Michigan⁶

• Rate : The incidence rate is 40.7 with a 95% confidence interval from 40.0 to 41.5 and 2,504 average annual cases over 2017-2021.
• CI*Rank ⋔ : 36 (26, 44)
• Percent of Cases with Late Stage : 30.6

North Carolina⁶

• Rate : The incidence rate is 45.4 with a 95% confidence interval from 44.6 to 46.1 and 2,859 average annual cases over 2017-2021.
• CI*Rank ⋔ : 5 (2, 11)
• Percent of Cases with Late Stage : 30.3

Georgia³

• Rate : The incidence rate is 47.0 with a 95% confidence interval from 46.2 to 47.7 and 2,885 average annual cases over 2017-2021.
• CI*Rank ⋔ : 2 (1, 5)
• Percent of Cases with Late Stage : 34.6

Ohio⁶

• Rate : The incidence rate is 44.2 with a 95% confidence interval from 43.5 to 44.9 and 3,227 average annual cases over 2017-2021.
• CI*Rank ⋔ : 10 (5, 18)
• Percent of Cases with Late Stage : 32.0

Illinois³

• Rate : The incidence rate is 44.5 with a 95% confidence interval from 43.8 to 45.2 and 3,402 average annual cases over 2017-2021.
• CI*Rank ⋔ : 7 (4, 16)
• Percent of Cases with Late Stage : 32.3

Pennsylvania⁶

• Rate : The incidence rate is 41.9 with a 95% confidence interval from 41.2 to 42.6 and 3,451 average annual cases over 2017-2021.
• CI*Rank ⋔ : 26 (17, 36)
• Percent of Cases with Late Stage : 30.4

New York³

• Rate : The incidence rate is 40.9 with a 95% confidence interval from 40.4 to 41.4 and 5,026 average annual cases over 2017-2021.
• CI*Rank ⋔ : 35 (27, 42)
• Percent of Cases with Late Stage : 29.4

Florida⁶

• Rate : The incidence rate is 42.5 with a 95% confidence interval from 42.0 to 43.1 and 5,952 average annual cases over 2017-2021.
• CI*Rank ⋔ : 21 (13, 29)
• Percent of Cases with Late Stage : 31.4

Texas³

• Rate : The incidence rate is 40.3 with a 95% confidence interval from 39.9 to 40.8 and 6,100 average annual cases over 2017-2021.
• CI*Rank ⋔ : 39 (32, 45)
• Percent of Cases with Late Stage : 32.7

California³

• Rate : The incidence rate is 41.8 with a 95% confidence interval from 41.4 to 42.2 and 9,240 average annual cases over 2017-2021.
• CI*Rank ⋔ : 28 (20, 34)
• Percent of Cases with Late Stage : 32.7

Indiana⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 10/11/2024 7:44 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.
¹ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
³ Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
⁵ Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
⁶ Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.